| Literature DB >> 20668075 |
Michael B Gill1, Janet S May, Susanna Colaco, Philip G Stevenson.
Abstract
Viral enzymes that process small molecules provide potential chemotherapeutic targets. A key constraint-the replicative potential of spontaneous enzyme mutants-has been hard to define with human gammaherpesviruses because of their narrow species tropisms. Here, we disrupted the murid herpesvirus 4 (MuHV-4) ORF61, which encodes its ribonucleotide reductase (RNR) large subunit. Mutant viruses showed delayed in vitro lytic replication, failed to establish infection via the upper respiratory tract, and replicated to only a very limited extent in the lower respiratory tract without reaching lymphoid tissue. RNR could therefore provide a good target for gammaherpesvirus chemotherapy.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20668075 PMCID: PMC2950598 DOI: 10.1128/JVI.00828-10
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103